Search
for
Sort by
Research 61–90 of 1000+
- ANTIANDROGEN TREATMENT OF POLYCYSTIC OVARY SYNDROME
- Sexual Hormones in Human Skin
- Hirsutism: Diagnosis and Treatment
- Assessment, diagnosis and treatment of a patient with hirsutism
- Metformin or Antiandrogen in the Treatment of Hirsutism in Polycystic Ovary Syndrome
- Dihydrotestosterone Stimulates 5a-Reductase Activity in Pubic Skin Fibroblasts*
- Sequential estrogen-progestin addition to gonadotropin-releasing hormone agonist suppression for the chronic treatment of ovarian hyperandrogenism: a pilot study.
- The Effects of Metformin, Ethinyl Estradiol/Cyproterone Acetate, and Metformin Ethinyl Estradiol/Cyproterone Acetate Combination Therapy on Carotid Artery Intima-media Thickness in Patients with Polycystic Ovary Syndrome
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Prospective metabolic evaluation of 150 consecutive patients who underwent gastric exclusion
- Is the metabolism of testosterone to 5α-dihydrotestosterone required for androgen action in the skin?
- Ethyl acetate fraction of Eclipta alba: a potential phytopharmaceutical targeting adipocyte differentiation
- The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review
- In silico analysis of ethyl acetate Bruguiera gymnorhiza leaf extracts as an anti-inflammatory agent
- Vitamin D, Lipid Metabolism and Prostate Cancer
- NAD⁺ Biology in Ageing and Chronic Disease: Mechanisms and Evidence across Skin, Fertility, Osteoarthritis, Hearing and Vision Loss, Gut Health, Cardiovascular–Hepatic Metabolism, Neurological Disorders, and Muscle
- To evaluate the outcome of combined therapy of cyproterone acetate and ethinyl estradiol in PCOS
- Treatment of idiopathic facial hirsutism with medroxyprogesterone acetate iontophoresis
- Relationships Between Biochemical Markers of Hyperandrogenism and Metabolic Parameters in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Gynecologic and andrologic dermatology and the metabolic syndrome
- Geranyl Acetate Attenuates Para-phenylenediamine-induced Cytotoxicity, DNA Damage, Apoptosis, and Inflammation in HaCaT Keratinocytes
- Ethinylestradiol/Chlormadinone Acetate for Use in Dermatological Disorders
- Finasteride, A Steroid 5α-Reductase Inhibitor, Does Not Affect the Oxidative Metabolism of Antipyrine
- Quantitative Determination of α-Tocopherol and α-Tocopheryl Acetate in Pharmaceutical and Supplementary Soft Capsules by High Performance Liquid Chromatography
- Synergistic Effects of Cinnamomum zeylanicum and Inositol on Metabolic and Hormonal Parameters in Women with Polycystic Ovary Syndrome
- Toxicity of the pharmaceuticals finasteride and melengestrol acetate to benthic invertebrates
- Effects of Oral Contraceptives Containing Desogestrel and Drospirenone on Clinical, Hormonal, and Metabolic Parameters of the Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial
- Effects of antiandrogen therapy of cyproteron acetate on androgen effects on the skin including androgenetic alopecia in menopausal women – case report: 10 years follow up –
- Endocrine evaluation of hirsutism